|
| ||
|
Pedi-Tips |
||
UTMB to Test H1N1 Virus Vaccine in ChildrenFor immediate release: Aug. 14, 2009 GALVESTON, Texas – The University of Texas Medical Branch at Galveston has been selected by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to conduct pediatric vaccine trials for the H1N1 (swine flu) virus. The pediatric trials are especially important for several reasons, said Dr. Christine Turley, principal investigator for the study, vice chairwoman for pediatric clinical services, and a scientist with the Sealy Center for Vaccine Development at UTMB. She explained that the virus potentially could affect younger people particularly hard. Turley said that there could be another outbreak of the flu just as school begins, making the trials even more important to families across the nation. “We want to help parents protect their children from this disease,” Turley said. “The virus could hit pre-teens and teenagers especially hard. An effective vaccine will be an important part of the plan to protect the most vulnerable parts of our population. The help of the community is essential as we work to understand how best to produce an effective response to the pandemic.” According to Turley, because older individuals have been exposed to influenza viruses many times in previous seasons, researchers believe there is some protection that will cross over in their immune systems to the new virus strain. “However, because children have had so many fewer seasons of exposure to influenza, their immune systems are considered naïve and at much higher risk for serious illness and death than adults,” Turley said. “This is a key reason that the vaccine is being studied in children so quickly.” The government in April declared the H1N1 virus a public health emergency, and the World Health Organization has classified the H1N1 virus as a pandemic, which reflects the widespread nature of the outbreak. UTMB will be conducting the trials as part of the government-funded H1N1 vaccines trial effort, under a subcontract with Houston’s Baylor College of Medicine. Baylor is an NIAID Vaccine Treatment and Evaluation Unit, one of eight federally-funded sites taking part in studies that will help determine the best dose of experimental vaccines designed to protect against the H1N1 virus. In addition to Baylor and UTMB, other sites taking part in the pediatric vaccine trials include Cincinnati Children’s Hospital VTEU, Emory University VTEU, Saint Louis University VTEU, Seattle Children’s Hospital (affiliated with the Seattle Group Health Cooperative VTEU), the University of Iowa VTEU, the University of Maryland School of Medicine VTEU and Vanderbilt University VTEU. They will be joined by Children’s Mercy Hospital in Missouri and Duke University Medical Center Those interested in more information about the study or participating in the pediatric H1N1 virus vaccine trials being conducted at UTMB, please send an e-mail to pedicltl@utmb.edu or call Karen Waterman, Carrie Harrington or Diane Barrett at 409-772-1696.H1N1 Flu (Swine): How the flu spreads Valuable information from the CDC website (http://www.cdc.gov/H1N1FLU/) The main way that influenza viruses are thought to spread is from person to person in respiratory droplets of coughs and sneezes. This can happen when droplets from a cough or sneeze of an infected person are propelled through the air and deposited on the mouth or nose of people nearby. Influenza viruses may also be spread when a person touches respiratory droplets on another person or an object and then touches their own mouth or nose (or someone else’s mouth or nose) before washing their hands. To find out more about how to care for people at home with novel H1N1 flu, please click on the following link: http://www.cdc.gov/h1n1flu/guidance_homecare.htm Back to School & Immunizations Back to school time means more than just new backpacks and jeans, it also signals parents to check if their children's immunizations are up to date. This year in the State of Texas there are new requirements for immunizations that more closely conform with the CDC recommendations. These requirements are in effect beginning August 1, 2009. Hepatitis A Vaccine: All students entering kindergarten will be required to have two doses of Hepatitis A vaccine. Measles, Mumps, Rubelle (MMR) Vaccine: All students entering kindergarten will be required to have two doses of the measles, mumps, and rubella (MMR) vaccine. Varicella (chickenpox) Vaccine: All students entering kindergarten and 7th grade will be required to have two doses of the Varicella vaccine. A written statement from the parent (or legal guardian or managing conservator), school nurse or physician attesting to a child’s positive history of varicella disease (chickenpox), or of varicella immunity, is acceptable in lieu of either dose of varicella vaccine. Tetanus, Diptheria and acellular pertussis-containing Vaccine (Tdap): Meningococcal Vaccine: Beginning August 1, 2009, all students entering 7th grade will be required to have one dose of meningococcal vaccine. In addition, college freshmen or students in dorms are recommended to have a meningococcal vaccine. For more information visit http://immunizetexas.com/ |
Volume No.1, Issue No. 3 August 18, 2009
|
|
NOW OPEN! UTMB After Hours Pediatric Urgent Care opened August 1, 2009 at 2027 61st. Street in Galveston. The phone number is (409) 744-KIDS (5437). Our hours at the new location are Monday - Friday 5:30 p.m. to 10 p.m. Saturday and Sunday 10 a.m. to 8 p.m., Holidays - Noon to 8 p.m.
|
||
|
|
| |
|
Copyright 2009 The University of Texas Medical Branch. | ||